91 related articles for article (PubMed ID: 23820828)
61. Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.
Rodrigues H; Figueira I; Lopes A; Gonçalves R; Mendlowicz MV; Coutinho ES; Ventura P
PLoS One; 2014; 9(7):e93519. PubMed ID: 24991926
[TBL] [Abstract][Full Text] [Related]
62. Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke.
Cherry KM; Lenze EJ; Lang CE
J Neurophysiol; 2014 Jun; 111(12):2516-24. PubMed ID: 24671538
[TBL] [Abstract][Full Text] [Related]
63. Society for Neuroscience meeting. Pills and games help conquer fear.
Miller G
Science; 2003 Nov; 302(5649):1321. PubMed ID: 14631016
[No Abstract] [Full Text] [Related]
64. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
Hofmann SG; Smits JA; Rosenfield D; Simon N; Otto MW; Meuret AE; Marques L; Fang A; Tart C; Pollack MH
Am J Psychiatry; 2013 Jul; 170(7):751-8. PubMed ID: 23599046
[TBL] [Abstract][Full Text] [Related]
65. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
66. Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies.
Javitt DC
Am J Psychiatry; 2013 Jul; 170(7):699-702. PubMed ID: 23820828
[No Abstract] [Full Text] [Related]
67. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
Davis M; Ressler K; Rothbaum BO; Richardson R
Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
[TBL] [Abstract][Full Text] [Related]
68. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
Rothbaum BO
Am J Psychiatry; 2008 Mar; 165(3):293-6. PubMed ID: 18316423
[No Abstract] [Full Text] [Related]
69. Recent advances in the psychosocial treatment of social anxiety disorder.
Hofmann SG
Depress Anxiety; 2010 Dec; 27(12):1073-6. PubMed ID: 21132801
[No Abstract] [Full Text] [Related]
70. D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review.
Schade S; Paulus W
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26364274
[TBL] [Abstract][Full Text] [Related]
71. The Therapeutic Role of d-Cycloserine in Schizophrenia.
Goff D
Adv Pharmacol; 2016; 76():39-66. PubMed ID: 27288073
[TBL] [Abstract][Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
